This activity carries a fee of
to review the content and receive credit.
Time to Complete
November 1, 2014
November 1, 2017
2.00 / AMA PRA Category 1 Credit(s)TM 2.00 / CE for Nurses 2.00 / CE for Nurse Practitioners
Provided by Advancing Knowledge in Healthcare Inc.
Statement of Need
It is estimated that one out of three Americans suffers from some type of chronic pain and yet it remains a misunderstood and undertreated health condition. Chronic pain has been identified as the primary cause of disability in the U.S. (American Chronic Pain Association, 2014).
This activity is designed to change health provider attitudes on chronic pain and willingness to offer comprehensive assessment and comprehensive treatment.
This independent self study activity is designed for physicians and nursing professionals at all levels and settings in the healthcare industry.
Upon completion of this course, the participant will be able to:
Identify defining characteristics of chronic pain
Recognize the impact of chronic pain impacts on individuals, families and U. S. health care
Explain rationale for a comprehensive pain assessment
Explain rationale for a multi-modal and comprehensive treatment approach to chronic pain
Categorize pharmacologic and non-pharmacologic treatment modalities
Review available opioid and non-opioid analgesic preparations when considering rationale for treatment
Use current evidence to support recommended treatment approaches for common chronic pain conditions and syndromes
Mary Kathleen Ebener PhD, RN Dr. Ebener is employed by Florida State College at Jacksonville as the Associate Dean of Bachelor of Science in Nursing program. In addition, Dr. Ebener teaches courses related to nursing, health care and statistical analysis at the University of Phoenix, Jacksonville, Florida campus. She holds a BSN degree from Illinois Wesleyan University; her MSN is from Andrews University, MI; and her PhD. is from the University of Florida at Gainesville.
Dr. Ebener discloses no significant financial relationships with pharmaceutical or medical product manufacturers.
Accredited Provider Disclosure
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity.
Staff, Planners, and Reviewers Disclosure
Dorothy Caputo, MA, BSN, RN Lead Nurse Planner
Ms. Caputo discloses no significant financial relationships with pharmaceutical or medical product manufacturers.
Bernadette Marie Makar, MSN, NP-C, APRN-C Nurse Planner
Ms. Makar discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH planners and reviewers have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants: NCCPA accepts AMA PRA Category 1 Credit(s)TM from organizations accredited by ACCME.
CE for Nurses
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
AKH Inc., Advancing Knowledge in Healthcare is an approved provider for nursing continuing education by the Florida Board of Nursing #50-2560.
This activity is awarded 2.00 contact hours.
CE for Nurse Practitioners
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education.
Provider Number: 030803.
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard.
This activity is awarded 2.00 contact hours, which includes 0 hours of pharmacology. Program ID # 21441.
Disclosure of Unlabeled Use
This educational activity does not include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
AKH Inc.’s courses are designed solely to provide healthcare professionals with information to assist in their practice and professional development. The courses are researched thoroughly, utilizing current literature and including practical experiences. AKH’s courses are not to be considered a diagnostic tool to replace professional advice or treatment. The courses serve as a general guide to the healthcare professional, and therefore, they cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH educational courses do not endorse commercial products. The author(s) and the publisher specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the courses. AKH further disclaims any responsibility for undetected errors, or from the reader’s misunderstanding of the course.
In order to receive credit, participants should read the entire monograph, complete and submit an evaluation and score at least 70% on the self-assessment test. AKH Inc. allows for one (1) re-test at no additional charge; additional re-tests must be purchased again at the full cost. Certificates will be available in the transcripts upon successful completion of the self-assessment test. If you have questions about this CME/CE activity, please contact AKH Inc. at email@example.com.